These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 828757)

  • 41. Evaluation of clinical isolates of Pseudomonas aeruginosa for ribosomal resistance to tobramycin.
    Botha P; de Kock MJ; van Vuuren CJ; Fourie S; van Heerden C
    S Afr Med J; 1990 Sep; 78(5):258-9. PubMed ID: 2118277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies on disc method for tobramycin sensitivity test (author's transl)].
    Kanazawa Y; Kuramata T; Matsumoto K; Hoshida F
    Jpn J Antibiot; 1979 Oct; 32(10):1003-8. PubMed ID: 513281
    [No Abstract]   [Full Text] [Related]  

  • 43. [Resistance "in vitro" to several antibiotics of "Pseudomonas aeruginosa" strains isolated both in cases from the hospital and in cases from the outside. Considerations on the differences in the resistance between the two groups (author's transl)].
    Bucci M; Faggiani L
    Ann Sclavo; 1976; 18(5):743-8. PubMed ID: 829304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The sensitivity of Pseudomonas aeruginosa (pyocyanic bacillus) to antiseptics and antibiotics. IX. Effect of culture media on the antiseptogram].
    Delmotte A; Beumer J
    Therapie; 1976; 31(2):257-65. PubMed ID: 821171
    [No Abstract]   [Full Text] [Related]  

  • 45. Synergism of ceftizoxime and tobramycin for Pseudomonas aeruginosa.
    Kim C; Schick DG; Ashley MA; Montgomerie JZ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():57-62. PubMed ID: 6296030
    [No Abstract]   [Full Text] [Related]  

  • 46. Influence of a pulmonary surfactant on the in vitro activity of tobramycin against Pseudomonas aeruginosa.
    Caldwell EJ; Piper DS
    Antimicrob Agents Chemother; 1999 Dec; 43(12):3044. PubMed ID: 10651624
    [No Abstract]   [Full Text] [Related]  

  • 47.
    Pan X; Dong Y; Fan Z; Liu C; Xia B; Shi J; Bai F; Jin Y; Cheng Z; Jin S; Wu W
    Front Cell Infect Microbiol; 2017; 7():83. PubMed ID: 28352614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibiotic exposure and its relationship to postantibiotic effect and bactericidal activity: constant versus exponentially decreasing tobramycin concentrations against Pseudomonas aeruginosa.
    Li RC; Zhu ZY; Lee SW; Raymond K; Ling JM; Cheng AF
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1808-11. PubMed ID: 9257767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system.
    Anwar H; van Biesen T; Dasgupta M; Lam K; Costerton JW
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1824-6. PubMed ID: 2511804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of polysaccharide interactions on antibiotic susceptibility of Pseudomonas aeruginosa.
    Allison DG; Matthews MJ
    J Appl Bacteriol; 1992 Dec; 73(6):484-8. PubMed ID: 1283390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transient exposure to a physiologically-relevant concentration of calcium confers tobramycin resistance upon sessile cells of Pseudomonas aeruginosa.
    Hoyle BD; Costerton JW
    FEMS Microbiol Lett; 1989 Aug; 51(3):339-41. PubMed ID: 2511067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sensitivity of clinical isolates in the surgical field to aminoglycoside and clinical evaluation of tobramycin intravenous drip infusion (author's transl)].
    Iwai S; Jinno D; Yamamoto E; Yokota T; Okamura N; Takai K; Sato T; Kunimatsu M; Sakabe T
    Jpn J Antibiot; 1981 Oct; 34(10):1355-65. PubMed ID: 7334574
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of the E test in testing susceptibility of Pseudomonas aeruginosa to tobramycin.
    Rautelin H; Renkonen I; Renkonen OV
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):177-80. PubMed ID: 1396734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug sensitivity of Pseudomonas aeruginasa strains isolated from children].
    Bilińska M; Lesiak K; Lutyński R; Pajdak E
    Med Dosw Mikrobiol; 1976; 28(3):231-6. PubMed ID: 826739
    [No Abstract]   [Full Text] [Related]  

  • 55. Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa.
    Tunney MM; Ramage G; Field TR; Moriarty TF; Storey DG
    Antimicrob Agents Chemother; 2004 May; 48(5):1879-81. PubMed ID: 15105149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antibiotic sensitivity of 100 strains of Pseudomonas aeruginosa isolated at Dakar].
    Mora M; Castets M; Vézard ; Deriot H; Mallet M
    Bull Soc Med Afr Noire Lang Fr; 1972; 17(4):626-30. PubMed ID: 4199295
    [No Abstract]   [Full Text] [Related]  

  • 57. [Variability of Pseudomonas aeruginosa 1C--a degrader of alkylsulfates].
    Stavskaia SS; Krivets IA; Nastoiashchaia NI
    Mikrobiol Zh (1978); 1987; 49(2):3-6. PubMed ID: 3150490
    [No Abstract]   [Full Text] [Related]  

  • 58. [Tobramycin. 1978 review].
    De Rosa F; Palumbo M
    G Ital Chemioter; 1979; 26(1-2):33-40. PubMed ID: 400146
    [No Abstract]   [Full Text] [Related]  

  • 59. [Studies on the Pseudomonas aeruginosa infections--frequency, antibiotics sensitivity, OEP-HA titer (author's transl)].
    Satomi N; Haranaka K; Fukaya K; Kunii O; Mashimo K
    Kansenshogaku Zasshi; 1979 Apr; 53(4):167-74. PubMed ID: 112204
    [No Abstract]   [Full Text] [Related]  

  • 60. [Organisms encountered in urinary tract infections in the various groups of patients and antibiotic sensitivities (author's transl)].
    Nagai T
    Kansenshogaku Zasshi; 1979 Dec; 53(12):704-12. PubMed ID: 120395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.